RWE AG INH O.N./ DE0007037129 /
4/21/2021 9:57:18 PM | Chg. -0.380 | Volume | Bid9:59:50 PM | Ask9:59:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
32.710EUR | -1.15% | 206,182 Turnover: 6.74 mill. |
32.690Bid Size: 500 | 32.830Ask Size: 500 | 23.39 bill.EUR | 2.60% | 20.96 |
GlobeNewswire
12/3/2020
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evi...
GlobeNewswire
7/29/2020
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track...
GlobeNewswire
12/10/2019
Infrastructure and Energy Alternatives, Inc. Announces Two Wind Construction Project Awards in Texas...
GlobeNewswire
11/21/2019
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommend...
GlobeNewswire
8/14/2019
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evi...
GlobeNewswire
3/27/2019
$1.64 Bn Real World Evidence (RWE) Solutions Market by Component, Application, End User - Global For...
GlobeNewswire
12/7/2017
Future Farm Hires RwE In Preparation For Spin Off Of New Augmented Reality Cannabis Company